We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

University of Washington Purchases arrayWoRx® Biochip Reader

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Applied Precision, LLC has announced that the University of Washington (UW)  has purchased its arrayWoRx® Biochip Reader to enhance its genomics research efforts.

Researchers from the UW School of Medicine's Department of Genome Sciences worked closely with Applied Precision to conduct a thorough evaluation of the system for use in array comparative genome hybridization (arrayCGH) scanning.

According to Researchers, the arrayWoRxe Biochip Reader was selected because it generates highly accurate and repeatable quantitative data, as well as provides application flexibility necessary for arrayCGH scanning.

“ArrayCGH is a new screening tool for genetic research that provides high-resolution genome analysis technology to detect copy number variation, including segmented chromosomal deletions and duplications without actually looking at chromosomes,” said Evan Eichler, Associate Professor at the University of Washington's Department of Genome Sciences.

“After an intense evaluation of different platforms, Applied Precision's arrayWoRxe Biochip Reader was found to provide the most reproducible results and will play a key role in the laboratory's arrayCGH scanning efforts.”

“The accuracy, speed and application flexibility of the arrayWoRxe microarray scanning system will enable the university to harness the significant potential arrayCGH scanning holds for genomics research and discovery efforts.”

“ArrayCGH scanning is a powerful example of how the arrayWoRxe Biochip Reader is enabling new microarray scanning applications - now being adopted by leading research, clinical and diagnostic laboratories,” said Brent Navran, Life Sciences Product Line Manager for Applied Precision.

“Genome-wide screening for chromosomal imbalances is already providing a wealth of new data on previously unrecognized tumor-specific genomic alterations.”

“Conducting such CGH analysis on microarrays using defined DNA probes with the arrayWoRxe Biochip Reader significantly enhances both data accuracy and speed of collection.”

“We look forward to future collaborations and to supporting the valuable, leading-edge scientific research conducted by the University of Washington.”

Applied Precision's arrayWoRxe Biochip Reader is designed to offer superior application flexibility.

The system achieves an unmatched 3.25 micron per pixel image resolution for life science applications, due to the integration of leading-edge and proprietary mechanical and optical systems.

Full-spectrum white light-based four color imaging technology, with a range of 350nm to 750nm, improves photon collection and also contributes to the lowest ratio coefficient of variation (CVr) in the industry, so that usable data is acquired and faulty data eliminated.

The system's intuitive automated preset scanning software, combined with simultaneous scanning and analysis technology, simplifies and speeds the imaging and analysis process.

In addition, changing wavelengths simply requires using different optical filters, while the standard model includes filter sets that support up to 89 low-cost fluorescent dies-contributing to both robust application flexibility and low cost of ownership.